Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Closed-loop TCI Based on New BIS Baseline in the Presence of Low Dose of Esketamine: a Randomized Controlled Equivalence Trial.

NCT06729892 is registered in ClinicalTrials.gov with bo xu as lead sponsor.

NCT NCT06729892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06729892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Closed-loop TCI Based on New BIS Baseline in the Presence of Low Dose of Esketamine: a Randomized Controlled Equivalence Trial.
Lead sponsor
bo xu
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 20, 2025
Completion date
May 30, 2025
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

closed-loop, general anesthesia with propofol